A prospective Randomised Controlled Trial assessing recombinant Luteinising Hormone supplementation in patients with a relative reduction in Luteinising Hormone (LH) levels during Vitro Fertilisation/Intracytoplasmic sperm Injection (IVF/ICSI) treatment.
Phase 1
Recruiting
- Conditions
- Infertility treated with IVFLow serum LH levels during IVF treatment cycles.Reproductive Health and Childbirth - Fertility including in vitro fertilisation
- Registration Number
- ACTRN12610000064000
- Lead Sponsor
- IVFAustralia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 697
Inclusion Criteria
1) IVF/ICSI using long pituitary down regulation.
2) No more than 3 stimulated IVF/ICSI treatment cycles before.
3) Not reached 42nd birthday.
4) Consent to undergo study.
5) Regular menstrual cycle.
Exclusion Criteria
1) Oocyte donors.
2) Failure to achieve down regulation within 6 weeks of starting gonadotrophin releasing hormone agonist (GnRH a), are to be excluded for the study.
3) Patients who have already taken part in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Pregnancy Rate[at about 6 to 8 weeks gestation. defined as a fetal geart beat on ultrasound.]
- Secondary Outcome Measures
Name Time Method